Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
4fx2 | FMN | Flavodoxin |
PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
---|---|---|---|---|---|
4fx2 | FMN | Flavodoxin | / | 1.000 | |
1fx1 | FMN | Flavodoxin | / | 0.722 | |
1j9g | FMN | Flavodoxin | / | 0.607 | |
1bu5 | RBF | Flavodoxin | / | 0.596 | |
5fx2 | FMN | Flavodoxin | / | 0.593 | |
1azl | FMN | Flavodoxin | / | 0.590 | |
3f6r | FMN | Flavodoxin | / | 0.586 | |
2fx2 | FMN | Flavodoxin | / | 0.580 | |
5tgz | FMN | Cannabinoid receptor 1 | / | 0.574 | |
1aku | FMN | Flavodoxin | / | 0.561 | |
1wsb | FMN | Flavodoxin | / | 0.549 | |
1xyv | FMN | Flavodoxin | / | 0.543 | |
3f6s | FMN | Flavodoxin | / | 0.541 | |
1j8q | FMN | Flavodoxin | / | 0.538 | |
1akr | FMN | Flavodoxin | / | 0.537 | |
1c7f | FMN | Flavodoxin | / | 0.528 | |
1j9z | FMN | NADPH--cytochrome P450 reductase | / | 0.524 | |
1akw | FMN | Flavodoxin | / | 0.522 | |
3kaq | FMN | Flavodoxin | / | 0.515 | |
3kap | FMN | Flavodoxin | / | 0.512 | |
3f90 | FMN | Flavodoxin | / | 0.511 | |
4y7c | FMN | NADPH--cytochrome P450 reductase | / | 0.508 | |
4b14 | 4XB | Glycylpeptide N-tetradecanoyltransferase | / | 0.502 | |
5xr8 | FMN | Cannabinoid receptor 1 | / | 0.502 | |
4f1l | 0RY | Poly [ADP-ribose] polymerase 14 | 2.4.2.30 | 0.500 | |
3vo2 | FAD | Ferredoxin--NADP reductase | / | 0.499 | |
3ojx | FMN | NADPH--cytochrome P450 reductase | / | 0.498 | |
5xra | FMN | Cannabinoid receptor 1 | / | 0.497 | |
2fcr | FMN | Flavodoxin | / | 0.494 | |
4n82 | FMN | Ribonucleotide reductase (NrdI family protein), putative | / | 0.494 | |
1fnb | FAD | Ferredoxin--NADP reductase, chloroplastic | 1.18.1.2 | 0.493 | |
1xyy | FMN | Flavodoxin | / | 0.491 | |
2xve | FAD | Putative flavin-containing monooxygenase | / | 0.488 | |
4b12 | C23 | Glycylpeptide N-tetradecanoyltransferase | / | 0.488 | |
3nyt | ULP | UDP-2-acetamido-2-deoxy-3-oxo-D-glucuronate aminotransferase | 2.6.1.98 | 0.485 | |
1h42 | FAD | Ferredoxin--NADP reductase | 1.18.1.2 | 0.483 | |
4a32 | 2CD | Glycylpeptide N-tetradecanoyltransferase | / | 0.483 | |
1ja0 | FMN | NADPH--cytochrome P450 reductase | / | 0.480 | |
1ygk | RRC | Pyridoxal kinase | 2.7.1.35 | 0.478 | |
1bx1 | FAD | Ferredoxin--NADP reductase, chloroplastic | 1.18.1.2 | 0.477 | |
1d9i | 00P | Prothrombin | 3.4.21.5 | 0.476 | |
4af7 | FAD | Ferredoxin--NADP reductase, leaf isozyme, chloroplastic | 1.18.1.2 | 0.476 | |
1g6o | ADP | Cag alpha | / | 0.475 | |
2bn4 | FMN | NADPH--cytochrome P450 reductase | / | 0.475 | |
3mhp | FAD | Ferredoxin--NADP reductase, leaf isozyme, chloroplastic | 1.18.1.2 | 0.473 | |
3n3a | FMN | Protein NrdI | / | 0.473 | |
1rkw | PNT | HTH-type transcriptional regulator QacR | / | 0.471 | |
4twn | B96 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.470 | |
1ogi | FAD | Ferredoxin--NADP reductase | 1.18.1.2 | 0.469 | |
3ggs | 2FD | Purine nucleoside phosphorylase | 2.4.2.1 | 0.468 | |
4oxx | FMN | Cindoxin | / | 0.468 | |
1x8l | OXR | Retinol dehydratase | / | 0.467 | |
1ykg | FMN | Sulfite reductase [NADPH] flavoprotein alpha-component | / | 0.467 | |
4c1i | EH9 | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.467 | |
1mht | SAH | Modification methylase HhaI | 2.1.1.37 | 0.466 | |
1mkd | ZAR | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.466 | |
3dy8 | 5GP | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.466 | |
2jb4 | A14 | Isopenicillin N synthase | 1.21.3.1 | 0.465 | |
7mht | SAH | Modification methylase HhaI | 2.1.1.37 | 0.465 | |
1cf3 | FAD | Glucose oxidase | 1.1.3.4 | 0.464 | |
1czn | FMN | Flavodoxin | / | 0.464 | |
4nmb | FAD | Bifunctional protein PutA | / | 0.464 | |
1eq2 | ADQ | ADP-L-glycero-D-manno-heptose-6-epimerase | / | 0.463 | |
3itu | IBM | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.463 | |
5hwo | HMG | Hydroxymethylglutaryl-CoA synthase | / | 0.463 | |
1krh | FAD | Benzoate 1,2-dioxygenase electron transfer component | 1.18.1.3 | 0.462 | |
1mcz | RMN | Benzoylformate decarboxylase | 4.1.1.7 | 0.462 | |
2bu9 | HFV | Isopenicillin N synthase | 1.21.3.1 | 0.462 | |
1bjk | FAD | Ferredoxin--NADP reductase | 1.18.1.2 | 0.461 | |
1eji | THF | Serine hydroxymethyltransferase, cytosolic | / | 0.461 | |
1gjr | FAD | Ferredoxin--NADP reductase | 1.18.1.2 | 0.461 | |
2xvf | FAD | Putative flavin-containing monooxygenase | / | 0.461 | |
5mht | SAH | Modification methylase HhaI | 2.1.1.37 | 0.461 | |
1qti | GNT | Acetylcholinesterase | 3.1.1.7 | 0.460 | |
3zc3 | FAD | Ferredoxin--NADP reductase | 1.18.1.2 | 0.460 | |
1amo | FAD | NADPH--cytochrome P450 reductase | / | 0.459 | |
1ja1 | FMN | NADPH--cytochrome P450 reductase | / | 0.459 | |
2y6f | M9F | Isopenicillin N synthase | 1.21.3.1 | 0.459 | |
4b77 | 54M | Beta-secretase 1 | 3.4.23.46 | 0.459 | |
4bpr | FAD | Ferredoxin--NADP reductase | 1.18.1.2 | 0.459 | |
9mht | SAH | Modification methylase HhaI | 2.1.1.37 | 0.459 | |
1pq9 | 44B | Oxysterols receptor LXR-beta | / | 0.458 | |
4b2g | V1N | Uncharacterized protein | / | 0.458 | |
4iar | ERM | 5-hydroxytryptamine receptor 1B | / | 0.458 | |
2xup | TZ5 | Acetylcholinesterase | 3.1.1.7 | 0.457 | |
1bk0 | ACV | Isopenicillin N synthase | 1.21.3.1 | 0.456 | |
1fjx | SAH | Modification methylase HhaI | 2.1.1.37 | 0.456 | |
2jj2 | ANP | ATP synthase subunit beta, mitochondrial | 3.6.3.14 | 0.456 | |
3zoi | M2W | Isopenicillin N synthase | 1.21.3.1 | 0.456 | |
4gv4 | MEJ | Poly [ADP-ribose] polymerase 3 | 2.4.2.30 | 0.456 | |
4hfr | 14M | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.456 | |
4bfv | ZVV | Pantothenate kinase | 2.7.1.33 | 0.455 | |
4e2y | JHZ | Methyltransferase | / | 0.455 | |
4c43 | FAD | Ferredoxin--NADP reductase | 1.18.1.2 | 0.454 | |
4zzi | 1NS | NAD-dependent protein deacetylase sirtuin-1 | 3.5.1 | 0.454 | |
1ahn | FMN | Flavodoxin 1 | / | 0.453 | |
1nm6 | L86 | Prothrombin | 3.4.21.5 | 0.453 | |
1ypl | RA8 | Prothrombin | 3.4.21.5 | 0.453 | |
2ok8 | FAD | Ferredoxin--NADP reductase, apicoplast | / | 0.453 | |
3biz | 61E | Wee1-like protein kinase | 2.7.10.2 | 0.453 | |
3fhx | PXL | Pyridoxal kinase | 2.7.1.35 | 0.453 | |
4hf4 | 15H | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.453 | |
5a4v | QUE | Glutathione S-transferase F2 | 2.5.1.18 | 0.453 | |
2bf4 | FMN | NADPH--cytochrome P450 reductase | / | 0.452 | |
3kxo | KXO | Hematopoietic prostaglandin D synthase | / | 0.452 | |
3mht | SAH | Modification methylase HhaI | 2.1.1.37 | 0.452 | |
5fd8 | A5A | Putative carboxypeptidase yocD | / | 0.452 | |
4u14 | 0HK | Muscarinic acetylcholine receptor M3 | / | 0.452 | |
1nup | NMN | Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 3 | / | 0.451 | |
3hr4 | FMN | Nitric oxide synthase, inducible | 1.14.13.39 | 0.451 | |
4a95 | 9MT | Glycylpeptide N-tetradecanoyltransferase | / | 0.451 | |
5f54 | TMP | Single-stranded-DNA-specific exonuclease | / | 0.451 | |
1gw2 | FER | Peroxidase C1A | 1.11.1.7 | 0.450 | |
1t57 | FMN | Conserved protein | / | 0.450 | |
4da8 | BG2 | Purine nucleoside phosphorylase DeoD-type | 2.4.2.1 | 0.450 | |
4e90 | 7RG | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.450 | |
4kw5 | 1W6 | Decaprenylphosphoryl-beta-D-ribose oxidase | / | 0.450 | |
5hs1 | VOR | Lanosterol 14-alpha demethylase | / | 0.450 | |
2pbw | DOQ | Glutamate receptor ionotropic, kainate 1 | / | 0.449 | |
2pks | G44 | Prothrombin | 3.4.21.5 | 0.449 | |
4bfw | ZVW | Pantothenate kinase | 2.7.1.33 | 0.449 | |
4pab | THG | Dimethylglycine dehydrogenase, mitochondrial | 1.5.8.4 | 0.449 | |
2zu8 | GDD | Mannosyl-3-phosphoglycerate synthase | 2.4.1.217 | 0.448 | |
3b7d | CNI | Glutamate receptor 2 | / | 0.448 | |
3c1k | T15 | Prothrombin | 3.4.21.5 | 0.448 | |
4b1j | A1R | Poly(ADP-ribose) glycohydrolase | 3.2.1.143 | 0.448 | |
4mht | SAH | Modification methylase HhaI | 2.1.1.37 | 0.448 | |
1v3q | 2DI | Purine nucleoside phosphorylase | 2.4.2.1 | 0.447 | |
1yhj | R6C | Pyridoxal kinase | 2.7.1.35 | 0.447 | |
1yob | FMN | Flavodoxin 2 | / | 0.447 | |
2bdy | UNB | Prothrombin | 3.4.21.5 | 0.447 | |
2vt4 | P32 | Beta-1 adrenergic receptor | / | 0.447 | |
3sn7 | 540 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.447 | |
4bj9 | UHB | Tankyrase-2 | 2.4.2.30 | 0.447 | |
4jtq | FLP | Aldo-keto reductase family 1 member C2 | / | 0.447 | |
4nv0 | MG7 | 7-methylguanosine phosphate-specific 5'-nucleotidase | / | 0.447 | |
4o9c | COA | Acetyl-CoA acetyltransferase | 2.3.1.9 | 0.447 | |
4ubv | COA | Steroid 3-ketoacyl-CoA thiolase | / | 0.447 | |
5dp2 | NAP | CurF | / | 0.447 | |
1nce | CB3 | Thymidylate synthase | / | 0.446 | |
1q84 | TZ4 | Acetylcholinesterase | 3.1.1.7 | 0.446 | |
1zgv | 501 | Prothrombin | 3.4.21.5 | 0.446 | |
2a2c | ADP | N-acetylgalactosamine kinase | 2.7.1.157 | 0.446 | |
2b5o | FAD | Ferredoxin--NADP reductase | 1.18.1.2 | 0.446 | |
2v5u | FMN | Flavodoxin | / | 0.446 | |
3k4s | 0MO | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.446 | |
4gi4 | 0EX | Queuine tRNA-ribosyltransferase | 2.4.2.29 | 0.446 | |
4js0 | GNP | Cell division control protein 42 homolog | / | 0.446 | |
1k22 | MEL | Prothrombin | 3.4.21.5 | 0.445 | |
1skm | SAH | Modification methylase HhaI | 2.1.1.37 | 0.445 | |
1soj | IBM | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 3.1.4.17 | 0.445 | |
2bvs | 2CE | Prothrombin | 3.4.21.5 | 0.445 | |
2e9a | B28 | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.445 | |
2zcj | SAH | Modification methylase HhaI | 2.1.1.37 | 0.445 | |
3aos | JH2 | Hemolymph juvenile hormone binding protein | / | 0.445 | |
3bi6 | 396 | Wee1-like protein kinase | 2.7.10.2 | 0.445 | |
4arb | C57 | Acetylcholinesterase | 3.1.1.7 | 0.445 | |
4djv | 0KM | Beta-secretase 1 | 3.4.23.46 | 0.445 | |
1hfq | MOT | Dihydrofolate reductase | 1.5.1.3 | 0.444 | |
1sg0 | STL | Ribosyldihydronicotinamide dehydrogenase [quinone] | / | 0.444 | |
2g26 | 3LG | Renin | 3.4.23.15 | 0.444 | |
3g4g | D71 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.444 | |
3krf | IPE | Geranyl diphosphate synthase large subunit | / | 0.444 | |
4ara | C56 | Acetylcholinesterase | 3.1.1.7 | 0.444 | |
4gh6 | LUO | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.444 | |
1hb3 | SCV | Isopenicillin N synthase | 1.21.3.1 | 0.443 | |
1ogj | FAD | Ferredoxin--NADP reductase | 1.18.1.2 | 0.443 | |
1qiq | ACC | Isopenicillin N synthase | 1.21.3.1 | 0.443 | |
3dyq | PCG | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.443 | |
3lv1 | NAP | NAD(P)-dependent benzaldehyde dehydrogenase | 1.2.1.28 | 0.443 | |
3ojw | FMN | NADPH--cytochrome P450 reductase | / | 0.443 | |
3qe2 | FMN | NADPH--cytochrome P450 reductase | / | 0.443 | |
4gki | 0JN | Aminoglycoside 3'-phosphotransferase AphA1-IAB | / | 0.443 | |
4oex | 5EO | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.443 | |
5c1g | GDU | Histo-blood group ABO system transferase | / | 0.443 | |
1oc1 | ASV | Isopenicillin N synthase | 1.21.3.1 | 0.442 | |
1pd9 | CO4 | Dihydrofolate reductase | 1.5.1.3 | 0.442 | |
1ps9 | MDE | 2,4-dienoyl-CoA reductase | 1.3.1.34 | 0.442 | |
2b8j | ADN | Class B acid phosphatase | 3.1.3.2 | 0.442 | |
2c7q | SAH | Modification methylase HhaI | 2.1.1.37 | 0.442 | |
2i9k | SAH | Modification methylase HhaI | 2.1.1.37 | 0.442 | |
2jh6 | 894 | Prothrombin | 3.4.21.5 | 0.442 | |
2vbp | VB1 | Isopenicillin N synthase | 1.21.3.1 | 0.442 | |
3fhx | PLP | Pyridoxal kinase | 2.7.1.35 | 0.442 | |
3ppk | FNI | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.442 | |
3sni | 546 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.442 | |
4dri | RAP | Serine/threonine-protein kinase mTOR | 2.7.11.1 | 0.442 | |
4dri | RAP | Peptidyl-prolyl cis-trans isomerase FKBP5 | 5.2.1.8 | 0.442 | |
4g2j | 0WF | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.442 | |
1blz | ACV | Isopenicillin N synthase | 1.21.3.1 | 0.441 | |
1hb1 | OCV | Isopenicillin N synthase | 1.21.3.1 | 0.441 | |
1mv8 | GDX | GDP-mannose 6-dehydrogenase | 1.1.1.132 | 0.441 | |
1w06 | W05 | Isopenicillin N synthase | 1.21.3.1 | 0.441 | |
2fjd | SFD | Adenylylsulfate reductase, subunit A (AprA) | / | 0.441 | |
2rc6 | FAD | Ferredoxin--NADP reductase | / | 0.441 | |
2wu4 | HBP | Acetylcholinesterase | 3.1.1.7 | 0.441 | |
2xnv | VU3 | Soluble acetylcholine receptor | / | 0.441 | |
3bjc | WAN | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.441 | |
4fcb | 0T7 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.441 | |
4ky4 | 04J | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.441 | |
4n3l | 2FN | Prothrombin | 3.4.21.5 | 0.441 | |
1f20 | FAD | Nitric oxide synthase, brain | 1.14.13.39 | 0.440 | |
1mvt | DTM | Dihydrofolate reductase | 1.5.1.3 | 0.440 | |
2b01 | TUD | Phospholipase A2, major isoenzyme | 3.1.1.4 | 0.440 | |
2gvd | FKP | Adenylate cyclase type 2 | / | 0.440 | |
2gvd | FKP | Adenylate cyclase type 5 | / | 0.440 | |
2ohi | FMN | Type A flavoprotein FprA | 1 | 0.440 | |
2our | CMP | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.440 | |
2v2z | CDM | 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase | / | 0.440 | |
3ada | NAD | Subunit alpha of sarocosine oxidase | / | 0.440 | |
3g4k | ROL | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.440 | |
3rtn | RTN | Beta-secretase 1 | 3.4.23.46 | 0.440 |